Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2025-12-24 @ 11:19 PM
NCT ID:
NCT01794156
Eligibility Criteria:
Inclusion Criteria:
* primary diagnosis according to DSM-IV-TR criteria of OCD
* willingness to keep medication stable while participating in study
* willingness to undergo active psychological treatment
* willingness to undergo randomization into treatment modality
* fluency in either English or French.
* entry criteria do not exclude a secondary diagnosis on Axis I or II providing it does not require treatment or is deemed unlikely to significantly affect compliance with the current treatment plan.
* participants will also be screened on a brief battery of neuropsychological tests to ensure comparability of mental capacity between groups.
* no change in medication type or dose during the 12 weeks before treatment for antidepressants (4 weeks for anxiolytics. If antidepressant or medication as not been stable for at least 12 weeks, a stabilization period will be imposed. Other medication (e.g., anxiolytics) will have to be stable for at least four weeks.
Exclusion Criteria:
* presence of other principal axes 1 disorders requiring treatment
* evidence of suicidal intent
* evidence of current substance abuse
* evidence of current or past of suicidal intent
* evidence of current or past schizophrenia, bipolar disorder or organic mental disorder
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01794156
Study Brief:
Protocol Section:
NCT01794156